In adults with SIHD and hypertension, a BP target of less than 130/80 mm Hg is DBP: C-EO I SBP: B-R 2. Adults with SIHD and hypertension (BP 130/80 mm Hg) should be treated with medications (eg, GDMTS9.1-6 beta blockers, ACE inhibitors, or ARBs) for compelling indications (eg, previous MI, stable angina) as first-line therapy, with the addition of other drugs (eg, dihydropyridine CCBs, thiazide diuretics, and/or mineralocorticoid receptor antagonists) as needed to further DBP: C-EO I B-NR 3. In adults with SIHD with angina and persistent uncontrolled hypertension, the addition of dihydropyridine CCBs to GDMTS9.1-6 beta blockers is recommended.S9.1-8,S9.1-11,S9.1-12 IIa B-NR 4. In adults who have had a MI or acute coronary syndrome, it is reasonable to continue GDMT (S9.1-6) beta blockers beyond 3 years as long- term therapy for hypertension.S9.1-13,S9.1-14 IIb C-EO 5. Beta blockers and/or CCBs might be considered to control hypertension in patients with CAD (without HFrEF) who had an MI more than 3 years ago and have angina. Synopsis Hypertension is a major risk factor for ischemic heart disease. Numerous RCTs have demonstrated the benefits of antihy- pertensive drug therapy in reducing the risk of ischemic heart disease. The following recommendations apply only to man- agement of hypertension in patients with SIHD without HF. See Section 9.2 for recommendations for the treatment of patients with SIHD and HF. Figure 5 is an algorithm on management of hypertension in patients with SIHD. Recommendation-Specific Supportive Text 1. In patients with increased cardiovascular risk, reduction of SBP to <130/80 mm Hg has been shown to reduce CVD complications by 25% and all-cause mortality by 2. 